Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 26 Sep 2009):

Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants.

Full Abstract

OBJECTIVE: We hypothesized that higher cumulative doses of recombinant erythropoietin (rEPO) for extremely preterm infants during the first 6 postnatal weeks would improve developmental outcomes, as evidenced in evaluations with the Bayley Scales of Infant Development-II Revised. METHODS: This was a retrospective cohort study with a data set for a group (N = 366) of infants of <1500 g and < or =30 weeks of gestation that was created initially to examine the association between rEPO treatment and retinopathy of prematurity. Infants who underwent developmental follow-up evaluations at corrected age of >12 months were included. The associations between rEPO doses and higher Bayley Scales of Infant Development Psychomotor Developmental Index and Mental Developmental Index (MDI) scores were estimated in multivariate linear regression analyses. RESULTS: Eighty-two infants underwent developmental evaluations after 12 months. The median age of evaluation was 25 months. The median 6-week cumulative rEPO dose was 3750 U/kg. In multivariate analyses, Psychomotor Developmental Index (PDI) scores were associated with transfusions, female gender, birth weight, and 5-minute Apgar scores (R(2) = 0.39). MDI scores were associated with 6-week rEPO dose, female gender, prenatal steroid treatment for > or =48 hours, and breast milk feedings (R(2) = 0.40). CONCLUSIONS: These findings identify a dose-response relationship between rEPO treatment and improved MDI scores. They are consistent with findings of adult studies and animal brain injury models and await confirmation.

 

Author information

Author/s: Brown, Mark S (MS); Eichorst, Delphine (D); Lala-Black, Brenda (B); Gonzalez, Robin (R);

Affiliation: Department of Pediatrics, Eastern Maine Medical Center, 489 State St, Kelley 6, Bangor, ME 04401, USA. mbrown(-atsign-)emh.org

Journal and publication information

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

Journal: Pediatrics (Pediatrics), published in United States. (Language: eng)

Reference: 2009-Oct; vol 124 (issue 4) : pp e681-7

Dates: Created 2009/09/29; Completed 2009/10/23;

PMID: 19786428, status: MEDLINE (last retrieval date: 10/23/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Erythropoietin, Recombinant (0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

10/30/1996
8/30/2006
Higher Relevance Score (100)
Lower Relevance Score (67)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index